ATE366933T1 - Assaysystem zur erstbehandlung von darmerkrankungen - Google Patents

Assaysystem zur erstbehandlung von darmerkrankungen

Info

Publication number
ATE366933T1
ATE366933T1 AT99922946T AT99922946T ATE366933T1 AT E366933 T1 ATE366933 T1 AT E366933T1 AT 99922946 T AT99922946 T AT 99922946T AT 99922946 T AT99922946 T AT 99922946T AT E366933 T1 ATE366933 T1 AT E366933T1
Authority
AT
Austria
Prior art keywords
asca
sample
positive
individual
anca
Prior art date
Application number
AT99922946T
Other languages
English (en)
Inventor
Michael Walsh
Steven Rose
Original Assignee
Prometheus Lab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometheus Lab Inc filed Critical Prometheus Lab Inc
Application granted granted Critical
Publication of ATE366933T1 publication Critical patent/ATE366933T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56961—Plant cells or fungi
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/065—Bowel diseases, e.g. Crohn, ulcerative colitis, IBS

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99922946T 1998-05-15 1999-05-11 Assaysystem zur erstbehandlung von darmerkrankungen ATE366933T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US09/079,435 US6218129B1 (en) 1998-05-15 1998-05-15 Inflammatory bowel disease first step assay system

Publications (1)

Publication Number Publication Date
ATE366933T1 true ATE366933T1 (de) 2007-08-15

Family

ID=22150525

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99922946T ATE366933T1 (de) 1998-05-15 1999-05-11 Assaysystem zur erstbehandlung von darmerkrankungen

Country Status (7)

Country Link
US (1) US6218129B1 (de)
EP (1) EP1086376B1 (de)
AT (1) ATE366933T1 (de)
AU (1) AU3983099A (de)
CA (1) CA2331447C (de)
DE (1) DE69936523D1 (de)
WO (1) WO1999060403A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7138237B1 (en) * 2000-05-19 2006-11-21 Cedars-Sinai Medical Center Diagnosis, prevention and treatment of Crohn's disease using the OmpC antigen
US6872540B2 (en) * 2001-10-26 2005-03-29 Techlab, Inc. Method and apparatus for distinguishing Crohn's disease from ulcerative colitis and other gastrointestinal diseases by detecting the presence of fecal antibodies to Saccharomyces cerevisiae
US6986995B2 (en) * 2002-02-28 2006-01-17 Prometheus Laboratories, Inc. Methods of diagnosing liver fibrosis
ES2379066T3 (es) 2002-09-05 2012-04-20 Techlab, Inc. Método para distinguir la colitis ulcerosa de la enfermedad de Crohn detectando la presencia de anticuerpos citoplasmáticos antineutrófilos (ANCA) fecales
SE0203099D0 (en) * 2002-10-21 2002-10-21 A & Science Ab Publ Diagnosis of candidiasis and candidemia or invasive candida infection
US7785818B2 (en) * 2002-10-25 2010-08-31 Techlab, Inc. Inflammatory bowel disease and irritable bowel syndrome IBD-first chek diagnostic panel
US7670764B2 (en) * 2003-10-24 2010-03-02 Prometheus Laboratories Inc. Methods of diagnosing tissue fibrosis
US7592150B2 (en) * 2003-12-03 2009-09-22 Glycominds, Ltd Method for diagnosing diseases based on levels of anti-glycan antibodies
US20060205022A1 (en) * 2003-12-03 2006-09-14 Nir Dotan Method for diagnosing and prognosing inflammatory bowel disease and crohn's disease
AU2004294526A1 (en) * 2003-12-03 2005-06-16 Glycominds, Ltd Method for diagnosing diseases based on levels of anti-glycan antibodies
US20060154276A1 (en) * 2004-05-13 2006-07-13 Prometheus Laboratories Inc. Methods of diagnosing inflammatory bowel disease
US7759079B2 (en) * 2004-05-13 2010-07-20 Prometheus Laboratories Inc. Methods of diagnosing inflammatory bowel disease
US11268149B2 (en) 2004-12-08 2022-03-08 Cedars-Sinai Medical Center Diagnosis and treatment of inflammatory bowel disease
US7873479B2 (en) 2005-12-01 2011-01-18 Prometheus Laboratories Inc. Methods of diagnosing inflammatory bowel disease
US7943328B1 (en) 2006-03-03 2011-05-17 Prometheus Laboratories Inc. Method and system for assisting in diagnosing irritable bowel syndrome
US20100094560A1 (en) * 2006-08-15 2010-04-15 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
US20080085524A1 (en) * 2006-08-15 2008-04-10 Prometheus Laboratories Inc. Methods for diagnosing irritable bowel syndrome
US8685741B1 (en) 2007-03-07 2014-04-01 Nestec S.A. Methods for diagnosing irritable bowel syndrome
US20100255513A1 (en) 2007-03-30 2010-10-07 Denson Lee A Serological markers of inflammatory bowel disease phenotype and disease progression
WO2009069007A2 (en) * 2007-11-30 2009-06-04 Glycominds, Ltd. Composition and method for prediction of complicated disease course and surgeries in crohn's disease
US8532931B2 (en) * 2008-09-07 2013-09-10 Edward Lakatos Calculating sample size for clinical trial
EP2359137A4 (de) 2008-11-11 2012-05-30 Prometheus Lab Inc Verfahren zur vorhersage einer entzündlichen darmerkrankung (ibd) anhand serologischer marker
AU2010236568B2 (en) * 2009-04-14 2015-08-27 Société des Produits Nestlé S.A. Inflammatory bowel disease prognostics
CA2766157A1 (en) 2009-06-25 2010-12-29 Hua Gong Methods for diagnosing irritable bowel syndrome
WO2011060098A1 (en) 2009-11-10 2011-05-19 Prometheus Laboratories Inc. Methods for predicting post-surgery risk associated with ileal pouch-anal anastomosis
US8445215B1 (en) 2010-07-23 2013-05-21 Nestec S.A. Assays and methods for the detection of Crohn's disease
EP2630495B1 (de) 2010-10-18 2017-02-08 Nestec S.A. Verfahren zur bestimmung von gegen medikamente gerichtete antikörperisotypen
WO2015067913A1 (en) 2013-11-07 2015-05-14 Diagnodus Limited Biomarkers
MX362132B (es) 2011-05-10 2019-01-07 Nestec Sa Metodos para perfilado de actividad de enfermedad para manejo de terapia personalizado.
WO2012158831A1 (en) 2011-05-16 2012-11-22 Prometheus Laboratories Inc. Performance of a biomarker panel for irritable bowel syndrome
SG11201401536QA (en) 2011-10-21 2014-05-29 Nestec Sa Methods for improving inflammatory bowel disease diagnosis
JP2015532425A (ja) 2012-10-05 2015-11-09 ネステク ソシエテ アノニム 粘膜治癒を予測及びモニタリングするための方法
MX367046B (es) * 2013-05-24 2019-08-02 Soc Des Produits Nestle S A Star Marcadores especificos de via para diagnosticar sindrome del intestino irritable.
CN103293301A (zh) * 2013-06-17 2013-09-11 天津瑞华生物科技有限公司 人自身免疫性疾病溃疡性结肠炎诊断试剂盒及其制备方法
CA2932569A1 (en) 2013-12-03 2015-06-11 Nestec S.A. Signaling pathways in tissues from inflammatory bowel disease patients
WO2015166461A1 (en) 2014-05-01 2015-11-05 Nestec S.A. Methods of selecting treatment regimen using tnf alpha and anti-tnf alpha drug levels
WO2016063204A1 (en) 2014-10-20 2016-04-28 Nestec S.A. Methods for prediction of anti-tnf alpha drug levels and autoantibody formation
MX2017006959A (es) 2014-12-02 2017-08-10 Nestec Sa Metodos para establecer un regimen de dosificacion de vedolizumab para tratar pacientes con enfermedad del intestino irritable.
CN108780088A (zh) 2015-11-06 2018-11-09 维蒂卡实验室公司 在伴侣动物中检测炎症标志物和治疗炎性病症的方法
KR20200069333A (ko) 2017-10-10 2020-06-16 프로메테우스 바이오사이언시즈, 인크. 베돌리주맙 치료를 모니터링하는 방법

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5691151A (en) * 1994-10-07 1997-11-25 Regents Of University Of California Methods of screening for ulcerative colitis and crohn's disease by detecting VH3-15 autoantibody and panca
US5874233A (en) * 1996-04-12 1999-02-23 Cedars-Sinai Medical Center Methods of diagnosing a clinical subtype of Crohn's disease with features of ulcerative colitis
US6183951B1 (en) * 1997-04-11 2001-02-06 Prometheus Laboratories, Inc. Methods of diagnosing clinical subtypes of crohn's disease with characteristic responsiveness to anti-Th1 cytokine therapy

Also Published As

Publication number Publication date
EP1086376A4 (de) 2005-01-19
US6218129B1 (en) 2001-04-17
DE69936523D1 (de) 2007-08-23
CA2331447C (en) 2007-03-27
WO1999060403A1 (en) 1999-11-25
CA2331447A1 (en) 1999-11-25
EP1086376B1 (de) 2007-07-11
EP1086376A1 (de) 2001-03-28
WO1999060403A9 (en) 2000-02-24
AU3983099A (en) 1999-12-06

Similar Documents

Publication Publication Date Title
ATE366933T1 (de) Assaysystem zur erstbehandlung von darmerkrankungen
WO2001011334A3 (en) Method of diagnosing irritable bowel syndrome and other diseases by detecting anti-saccharomyces cerevisiae antibody
DK0943097T3 (da) Fremgangsmåde til at påvise IgE
DK1141728T3 (da) Påvisning af nyresygdom og behandling deraf
WO2003036256A3 (en) Method and apparatus for increasing the dynamic range and accuracy of binding assays
CY1107621T1 (el) Μεθοδος ανιχνευσης αντισωματων σε ενα δειγμα
WO2004048600A3 (en) Diagnostic tests and methods for diagnosing inflammatory bowel disease
DESPLAT‐JEGO et al. Evaluation of the BioPlex 2200 ANA screen for the detection of antinuclear antibodies and comparison with conventional methods
DE60119079D1 (de) System und verfahren für immunologische assays
EP1444519A4 (de) Verfahren und vorrichtung zur unterscheidung von morbus crohn von ulzerativer colitis und anderen magen-darm-erkrankungen durch nachweis des vorhandenseins von antikörpern gegen saccharomyces cerevisiae in faeces
DE69628847D1 (de) Testverfahren und testsatz zur diagnose von autoimmunerkrankungen
EP0585960A3 (de) Diagnostisches Verfahren für Autoimmunkrankenheiten
Shulaw et al. Evidence of paratuberculosis in Ohio's white-tailed deer, as determined by an enzyme-linked immunosorbent assay
CA2213083A1 (en) Detection of antibody production
ATE208040T1 (de) Immunoassay-reagenzien, testsätze und verfahren
ATE192236T1 (de) Menschliche phospholipase aktivierender proteinteil
DE60038557D1 (en) Assay
WO1996010748A1 (en) Methods and materials for detecting autoimmune antibodies
ATE242487T1 (de) Verfahren zur bestimmung von schilddrüsen- autoantikörpern
MX9704717A (es) Antigeno, anticuerpos y ensayo de diagnostico para la enfermedad de alzheimer.
US20050233322A1 (en) Method for producing a nucleosome preparation and use thereof in in vitro diagnosis of disseminated lupus erythematosus (dle)
CN114878810A (zh) 风湿病自身抗体检测试剂盒及检测方法
DK0788595T3 (da) Fremgangsmåde til undersögelse af immumkompetance
WO2002044723A3 (en) Method for diagnosing a predisposition of psychosis in a progeny

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties